Assessing accuracy and precision of home quantitative urine beta hCG with serum for pregnancy of unknown location (CONNECT).
Primary Objective
This study is being done to assess the accuracy of an at-home urine test for the management of Pregnancy of Unknown Location (PUL).
Description
The current management of patients with PUL involves multiple trips to the clinic and/or hospital for blood draws and close monitoring of their pregnancy. Specifically, doctors are monitoring levels of a hormone called human Chorionic Gonadotropin (hCG). The hCG can be detected in blood and urine in early pregnancy, and hCG will rise as pregnancy progresses. This study is evaluating the use of the Mira Device in the monitoring of patients with a PUL. Mira is an at-home, lab-grade hormone tracking system that can monitor hCG levels in the urine. If the at-home urine testing proves to be accurate in monitoring hormone levels in patients with PUL, then there is the potential to reduce the number of visits and blood draws required of patients with a PUL.
Details
Locations
University of Colorado Hospital
Principal Investigator
Leslie Appiah
Study ID
Protocol Number: 22-1954
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers